2-Oxo-3-hydroxy-N-methyl-N-propyl D-Lysergamide-d3

2-Oxo-3-hydroxy-N-methyl-N-propyl D-Lysergamide-d3, also known as O-H-LSD-d3, is a deuterated variant of LSD, a well-known hallucinogenic drug. This compound is a synthetic derivative of lysergic acid that is commonly used for research purposes and is not intended for human consumption. Chemically, O-H-LSD-d3 is composed of a lysergic acid diethylamide (LSD) molecule that has undergone deuteration, the process of replacing hydrogen atoms with deuterium atoms. This modification provides researchers with a unique tool for studying the metabolism and pharmacokinetics of LSD and its derivatives. In terms of usage, O-H-LSD-d3 is primarily utilized in scientific research to investigate the pharmacological effects of LSD and other lysergamides on the human body. It is commonly used in pharmacokinetic and metabolic studies to determine how LSD is metabolized and excreted in the body. While O-H-LSD-d3 is not intended for human consumption, LSD and its derivatives are known for their potent psychoactive effects. These substances can cause hallucinations, altered perceptions, and changes in mood and thought patterns. As a result, LSD and its derivatives are classified as Schedule I controlled substances in the United States, indicating a high potential for abuse and no recognized medical use.